In breast cancers, absence of progesterone receptor (PR), human epidermal growth factor receptor‐2 (HER‐2), and estrogen receptor (ER) in immunohistochemical staining and in situ hybridization known as TNBC.5 Here, ESR1 is linked to breast carcinoma.